In vitro evaluation of HMGB1 removal with various membranes for continuous hemofiltration
2011

Removing HMGB1 from Blood During Hemofiltration

Sample size: 4 publication Evidence: moderate

Author Information

Author(s): Yumoto M, Nishida O, Moriyama K, Shimomura Y, Nakamura T, Kuriyama N, Hara Y, Yamada S, Miyasho T

Primary Institution: Fujita Health University School of Medicine

Hypothesis

Can HMGB1 be effectively removed from blood using different hemofiltration membranes?

Conclusion

Using HCO or AN69ST membranes for continuous hemofiltration can effectively remove HMGB1, which may help in treating sepsis.

Supporting Evidence

  • AN69ST membrane showed the highest capacity to adsorb HMGB1.
  • HMGB1 concentrations decreased significantly during hemofiltration.
  • Clearance rates for HMGB1 were markedly high with the AN69ST membrane.

Takeaway

This study tested different filters to see if they could clean a harmful protein from blood, and found that some filters worked really well.

Methodology

The study involved hemofiltration of a solution containing HMGB1 and albumin using different membrane types over a set period.

Limitations

The study was conducted in vitro, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc9534

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication